Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Effect of Tet2 loss in bone marrow progenitors
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
PubMed Full text in PMC Similar studies Analyze with GEO2R
Gene expression profiling in pre-leukemic hematopoietic stem cells carrying both NrasG12D/+ and Tet2+/- mutations
PubMed Full text in PMC Similar studies SRA Run Selector
Tet2 loss dysregulates the behavior of bone marrow derived mesenchymal stromal cells
PubMed Full text in PMC Similar studies
Tet2 loss dysregulates the behavior of bone marrow derived mesenchymal stromal cells [hME-Seal]
Tet2 loss dysregulates the behavior of bone marrow derived mesenchymal stromal cells [RNA-seq]
Identify the key signaling pathway involved in the Tet2 deficiency-induced clonal hematopoiesis
Non-catalytic functions of Tet2 are essential to regulate hematopoietic stem and progenitor cell homeostasis
DNMT3A and TET2 Mutations Increase Hematopoietic Stem Cell Fitness Through Distinct Mechanisms
DNMT3A and TET2 Compete and Cooperate to Repress Differentiation Lineage-Specific Factors in Hematopoietic Stem Cells
Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis [Agilent]
Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis [ChIP-seq]
Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis
Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis (Affymetrix)
Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis (eRRBS)
Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis (MeDIP-seq)
PU.1-dependent enhancer inhibition separates clonal hematopoiesis from malignant transformation (oxBS-Seq)
PU.1-dependent enhancer inhibition separates Tet2 deficient clonal hematopoiesis from malignant transformation
PU.1-dependent enhancer inhibition separates clonal hematopoiesis from malignant transformation (ATAC-Seq)
PU.1-dependent enhancer inhibition separates clonal hematopoiesis from malignant transformation (RNA-Seq)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on